Physician profile
Barry Sporer
NPI 1821165671
$496.27
in general payments reported to CMS, 2019-2025
9 companies · $98.91 in 2025
The $98.91 reported for 2025 was less than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $34.76 · 2023: $61.05 · 2024: $68.32 · 2025: $98.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Implants North America INC | $209.90 | 2019-2020 | |
| Orapharma, A Division of Bausch Health US, LLC | $60.99 | 2023-2025 | Arestin, Ossix Plus |
| Dentsply Sirona INC | $58.08 | 2024-2025 | Midwest Stylus Plus, Cavitron |
| Carestream Dental, LLC | $45.06 | 2019 | |
| Nobel Biocare USA | $40.63 | 2023 | Nobelactive |
| Philips North America LLC | $24.27 | 2025 | Whitening Pens |
| Straumann USA LLC | $22.86 | 2024 | |
| Voco America INC. | $21.45 | 2024 | Futurabond U, Admira Fusion X-Tra, Voco Retraction Paste |
| Geistlich Pharma, North America, INC. | $13.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Sporer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.